REPL
Replimune Group, Inc. · Healthcare
Executive Chair Philip Astley-Sparke sold $245K of Replimune Group, Inc.
Sold$245,394
$6.47Price
37,928Shares
−2%Stake
What REPL did after the filing
Prices for REPL after this filing aren't in yet.
Traded Thu, May 16. Filed Mon, May 20, 8:04 PM ET, after the close. Not investment advice.